Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Betamethasone + hyaluronic acid is a combination medication used primarily for intra-articular injections to treat inflammatory joint conditions such as osteoarthritis. Betamethasone is a corticosteroid with anti-inflammatory, immunosuppressive, and antiproliferative properties, while hyaluronic acid provides lubrication and cushioning in joint spaces. This combination is used to reduce pain, inflammation, and improve joint mobility in conditions like knee osteoarthritis. It has also been studied for use in temporomandibular joint disorders and in topical formulations for treating conditions like phimosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on betamethasone + hyaluronic acid.